Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update Nanotech Investing
CVD Equipment Corporation to Report Third Quarter 2025 Financial Results on November 10, 2025 Technology Investing
Cullinan Therapeutics to Showcase New Data Demonstrating Compelling Clinical Activity for CLN-049, a Novel FLT3xCD3 T Cell Engager, in AML Patients in an Oral Presentation at the 67th ASH Annual Meeting Nanotech Investing
RZOLV Reports Approximately 97.0% Gold Recovery on Complex Copper-Gold Ore Without Pretreatment, Highlighting Potential to Simplify Flowsheets Versus Cyanide
RZOLV Reports Approximately 97.0% Gold Recovery on Complex Copper-Gold Ore Without Pretreatment, Highlighting Potential to Simplify Flowsheets Versus Cyanide
